The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.50 (7.41%)
Spread: 0.50 (7.143%)
Open: 6.75
High: 7.25
Low: 6.75
Prev. Close: 6.75
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of options

27 Mar 2023 07:00

RNS Number : 2333U
Braveheart Investment Group plc
27 March 2023
 

27 March 2023

Braveheart Investment Group plc

("Braveheart" or the "Company")

 

Grant of options

 

Braveheart Investment Group (AIM: BRH), announces that, on 24 March 2023, the Company granted options over a total of 2,950,000 ordinary shares of 2p each in the Company ("Ordinary Shares") to the Directors and a service provider to the Company (the "Options"). The Options have been granted pursuant to the Company's share option plan adopted on 16 December 2020. 

 

In order to be eligible to receive new EMI options, Vivian Hallam, Executive Director, has, on 24 March 2023, surrendered 523,808 EMI options previously granted to him on 14 October 2021 and that had an exercise price of 31.5p.

 

In aggregate, 2,900,000 Options have been granted to Directors of the Company, as follows:

 

Name

No. options over Ordinary Shares previously held

No. Options granted

No. options over Ordinary Shares surrendered

Resultant holding of options over Ordinary Shares held

Percentage of the current issued share capital of the Company

Trevor Brown

1,500,000

1,250,000

-

2,750,000

4.3

Vivian Hallam

2,500,000

1,250,000

523,808

3,226,192

5.1

Susan Hagan

50,000

200,000

-

250,000

0.4

Qu Li

0

200,000

-

200,000

0.3

 

The Options granted to Vivian Hallam are EMI options and the Options granted to Trevor Brown, Susan Hagan and Qu Li are unapproved options. The exercise price of the Options is 7.75p, being the closing mid-market price of an Ordinary Share on 24 March 2023, the date of grant. The Options will vest from 27 March 2024 and be exercisable up to 27 March 2033, subject to continued employment. The Options granted to Trevor Brown and Vivian Hallam, as Executive Directors of the Company, have an additional performance related vesting criteria that the closing mid-market price of an Ordinary Share must exceed 9.6875p (being a 25% premium to the Option exercise price) for 10 business days out of a consecutive 30 business day period.

 

Following the grant of the Options and surrender of historic options held by Viv Hallam, the Company now has options outstanding over a total of 7,022,192 Ordinary Shares, equivalent to 11.0% of the Company's current issued share capital.

 

Further details of the Options can be found in the Notification of Dealing Form below.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Trevor Brown

Chief Executive Officer

Vivian Hallam

Executive Director

Susan Hagan

Non-Executive Director

Qu Li

Non-Executive Director

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

See 1a) above 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Braveheart Investment Group plc

b)

 

LEI

 

2138006HQ3COMU626I61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

GB00B13XV322

b)

 

Nature of the transactions

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

Price: Exercise price of 7.75p per option

 

Trevor Brown

1,250,000

Vivian Hallam

1,250,000

Susan Hagan

200,000

Qu Li

200,000

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

N/A

 

e)

 

Dates of the transaction

 

24 March 2023

f)

Place of transaction

Outside a trading venue

 

For further information:

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown CEO

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDGGDXXUDDGXL
Date   Source Headline
24th Nov 20147:00 amRNSCrowdcube Fund makes first four investments
23rd Sep 20147:00 amRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSDirectorate Change
22nd Sep 20142:10 pmRNSResult of AGM
1st Sep 20147:00 amRNSNotice of AGM
29th Aug 20143:16 pmRNSTotal Voting Rights
27th Aug 20147:00 amRNSDirector/PDMR Shareholding
20th Aug 20147:00 amRNSDirector/PDMR Shareholding
20th Aug 20147:00 amRNSAward of options
19th Aug 20147:00 amRNSDirector/PDMR Shareholding
14th Aug 201412:04 pmRNSHolding(s) in Company
14th Aug 201412:04 pmRNSHolding(s) in Company
11th Aug 20147:00 amRNSIssue of Equity
22nd Jul 20143:52 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSPreliminary Results
3rd Apr 20143:18 pmRNSHolding(s) in Company
3rd Apr 20141:32 pmRNSHolding(s) in Company
3rd Apr 20141:30 pmRNSHolding(s) in Company
1st Apr 20147:00 amRNSTotal Voting Rights
28th Mar 201411:29 amRNSAward for WhiteRock Capital Partners
25th Mar 20147:00 amRNSIssue of Equity and Directorate Change
31st Jan 20142:58 pmRNSTotal Voting Rights
31st Jan 20147:00 amRNSHolding(s) in Company
31st Jan 20147:00 amRNSHolding(s) in Company
27th Jan 20147:00 amRNSPartnership to launch co-investment fund
14th Jan 20147:00 amRNSIssue of Equity
18th Dec 20137:00 amRNSHalf Yearly Report
13th Dec 201312:29 pmRNSDisposal
11th Dec 20137:00 amRNSFinance Yorkshire Update
6th Dec 20137:00 amRNSWhiteRock Capital Partners update
26th Sep 20132:55 pmRNSResult of AGM
16th Sep 20137:00 amRNSEnvestors funds growth at FX firm Ebury Partners
4th Sep 20137:00 amRNSNotice of AGM
3rd Sep 20137:00 amRNSFinal Results
14th Aug 20137:00 amRNSWhiteRock Capital Partners update
26th Jul 20137:00 amRNSFirst exit from fund
11th Jun 20137:00 amRNSEnvestors announces its North strategy
16th May 20137:00 amRNSBraveheart's Envestors funds payasUgym
2nd May 20137:00 amRNSBraveheart announces Envestors funding for Loco2
22nd Apr 20137:00 amRNSEnvestors leads ComparaFinanza fundraising
15th Apr 20137:00 amRNSWhiteRock Capital Partners wins key industry award
12th Apr 20137:00 amRNSReorganisation of Yorkshire businesses
2nd Apr 20133:31 pmRNSDirectorate Change - amended
2nd Apr 20137:00 amRNSDirectorate Change
19th Mar 20137:00 amRNSAdviser change of name
22nd Feb 20133:45 pmRNSUpdate on WhiteRock and Growth Loan Fund -Amend
22nd Feb 20133:02 pmRNSUpdate on WhiteRock and Growth Loan Fund
21st Feb 20137:00 amRNSEnvestors closes funding for Cipher Surgical
4th Feb 20137:00 amRNSSubsidiary and office name change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.